尿素载体与口服生物可用抑制剂E3结合的结构特征
Shen-Ming Huang1,2, Bo-Yang Cai3, Lei Liu4,5
1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Beijing Key Laboratory of Cardiovascular Receptors Research, Peking University, Beijing, 100191, China. huangshenming@jnu.edu.cn.
针对脏尿素输送器 (UTs) 的新口服生物可用抑制剂提供了一种新的利尿剂方法. 结构研究揭示了抑制剂E3如何与UT-A2结合,为开发强大的UT抑制剂提供了洞察力.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 口服可生物利用的尿素载体 (UTs) 抑制剂为节盐利尿剂提供了潜在的途径.
- 它们的作用机制与传统的转运器向性尿剂不同.
研究的目的:
- 阐明口服尿道抑制剂和尿道抑制剂之间的相互作用机制.
- 确定一种新型抑制剂E3对UT-A2.2的抑制活性的结构基础.
主要方法:
- 低温电子显微镜被用来解决抑制剂E3与UT-A2.2复合的结构.
- 进行了结构分析和具有约束力的自由能源计算.
主要成果:
- 揭示了E3与UT-A2的结合方式.
- E3被确定为人类,小鼠和大鼠UT-A/UT-B的常见竞争性抑制剂.
- E3在UT通道的尿素结合口袋内竞争性地与保存的Q-T-T-Q动机结合.
- 确定了UT的BSBP区域对于提高不同UT的E3抑制功效至关重要.
结论:
- 这项研究提供了有价值的结构性见解,了解E3.3对UT抑制的机制.
- 这些发现可以指导设计和修改用于利尿剂应用的高 afinity UT 抑制剂.
更多相关视频
07:52Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
Published on: September 10, 2018
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
相关概念视频
Drug Elimination by Renal Route: Tubular Secretion
Pore Transport and Ion-Pair Transport
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Renal Drug Excretion: Tubular Secretion
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Hepatic Drug Clearance: Role of Transporters
Drug Elimination by Renal Route: Tubular Reabsorption
